Shasun

The company's standalone total income from operations, however, rose to Rs 270.03 crore during the quarter under consideration as against Rs 256.73 crore in the year ago period.

Shasun factory up for sale, jewellery lose sheen

Shasun Pharma has decided to sell it factory in Vishakhapatnam, which was built at a cost of Rs 130 crore. Subex has jumped over 15 percent since the beginning of this week Everready has bounced back after witnessing a 7 percent cut in two days Jewellery companies like Goenka and Shree Ganesh lose 12-13 percent this week

Buy SBI around Rs 2060, says Baliga

Ambareesh Baliga, Market Expert advice traders to buy SBI around Rs 2060.

Hold Ranbaxy Labs with stop loss of Rs 540: Anu Jain

Anu Jain of IIFL Private Wealth Management advice traders to hold Ranbaxy Labs with stop loss of Rs 540.

Capacity debottlenecking led to growth: Shasun Pharma

Abhaya Kumar, managing director, Shasun Pharmaceuticals Ltd says that capacity debottlenecking and higher customer demand contributed to 40% y-o-y growth. He also says that the company expects 25% growth in EPS of the company in FY13.